MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejps.2024.106783

Медицинская библиотека · European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2024

Hyaluronic acid modified extracellular vesicles targeting hepatic stellate cells to attenuate hepatic fibrosis.

Yu Fei, Liu Zongyu, Feng Jie, Man Yuhong, Zhang Huan, Shi Jingying, Pang Xiang, Yu Yang, Bi Ye

СтатьяПеревод пока не подготовлен

Аннотация

RATIONALE: Transforming growth factor-beta1 (TGF-β1) plays a pivotal role in promoting hepatic fibrosis, pirfenidone (PFD) could inhibit TGF-β1 signaling pathway to alleviate hepatic stellate cells (HSC) activation mediated hepatic fibrosis. The targeting delivery strategy of PFD to hepatic stellate cells is a challenge. Extracellular vesicles (EVs), cell-derived membranous particles are intraluminal nano-vesicles that play a vital role in intercellular communication, they also be considered as an ideal nano-carrier.

METHODS

In this study, we developed a target strategy to deliver PFD to HSC with CD44 over-expression by EVs, hyaluronic acid (HA) modified DSPE-PEG2000 endows the active targeting ability of activated HSCs to PFD-loaded EVs.

RESULTS

In both rat hepatic stellate cell line HSC-T6 and rat hepatocyte cell line BRL, HA@EVs-PFD demonstrated the capacity to down-regulate the expression of collagen-synthesis-related proteins and showed superior inhibition efficacy of HSC-T6 activation compared to free PFD. In hepatic fibrosis model, 4 weeks of HA@EVs-PFD treatment resulted in a reduction in liver collagen fibers, significant improvement in hepatic cell morphology, and amelioration of hepatic fibrosis.

CONCLUSIONS

HA@EVs-PFD, as a drug delivery system that effectively targets and inhibits activated HSCs to treat hepatic fibrosis, holds promise as a potential therapeutic agent against hepatic fibrosis.

Для цитирования: Yu Fei, Liu Zongyu, Feng Jie, Man Yuhong, Zhang Huan, Shi Jingying, Pang Xiang, Yu Yang, Bi Ye. Hyaluronic acid modified extracellular vesicles targeting hepatic stellate cells to attenuate hepatic fibrosis.. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2024. DOI: 10.1016/j.ejps.2024.106783.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.